WASHINGTON (AP) 鈥� youngest brother said in a radio interview Wednesday that the president has been 鈥渧ery open-minded鈥� in conversations the two have had about the benefits of psychedelics as a form of medical treatment.
Frank Biden made the comments during a call into The Michael Smerconish Program on SiriusXM. The host had just interviewed a reporter who recently wrote about powerful Silicon Valley entrepreneurs and employees who believe the use of psychedelics and similar substances can help lead to business breakthroughs.
鈥淗e is very open-minded," Frank Biden said when asked by Smerconish about conversations he's had with the president on the topic. "Put it that way. I don鈥檛 want to speak, I鈥檓 talking brother-to-brother. Brother-to-brother," the younger Biden said. "The question is, is the world, is the U.S. ready for this? My opinion is that we are on the cusp of a consciousness that needs to be brought about to solve a lot of the problems in and around addiction, but as importantly, to make us aware of the fact that we鈥檙e all one people and we鈥檝e got to come together.鈥�
Frank Biden added that he had 鈥渄one a great deal of research鈥� on the issue 鈥渂ecause I鈥檓 a recovering alcoholic for many, many years.鈥�
The White House did not respond to a request for comment.
Some researchers believe psilocybin, the compound in psychedelic mushrooms, the brain organizes itself and can help users overcome things like depression, alcoholism and post-traumatic stress disorder. A drug that鈥檚 related was cleared by the FDA to .
But medical experts caution that more research is needed on the drugs鈥� efficacy and the extent of the risks of psychedelics, which can cause hallucinations.
The American Psychiatric Association , noting the Food and Drug Administration has yet to offer a final determination. The FDA designated psilocybin as a 鈥渂reakthrough therapy鈥� in 2018, a label that鈥檚 designed to speed the development and review of drugs to treat a serious condition. MDMA, also known as ecstasy, also has that designation for PTSD treatment.
The FDA last week released for researchers designing clinical trials testing psychedelic drugs as potential treatments for a variety of medical conditions. The Biden administration has also provided to the National Institutes of Health and other agencies funding for with potential benefit for mental and behavioral health.
Earlier this year, Oregon became the first state in the nation to Colorado鈥檚 voters last year voted to decriminalize psilocybin.
Republican strongholds, , have or are considering commissioning studies into the drugs, partly inspired by veterans鈥� who have used psilocybin to help with PTSD.
Former Texas Republican Gov. Rick Perry spoke at a conference last week in Colorado about helping get a bill passed in the to fund a study of psilocybin for veterans. He doesn鈥檛 support recreational use.
In Congress, similar veteran-focused proposals brought progressive Democratic Rep. Alexandria Ocasio-Cortez from New York and far-right Rep. Matt Gaetz from Florida into an unlikely alignment.
Aamer Madhani And Jesse Bedayn, The Associated Press
